Assessment of Clinical Response to JAK Inhibition in Patients With Familial Chilblain Lupus and TREX1 Mutation

This case series evaluates the clinical response to the Janus kinase inhibitor baricitinib in 3 individuals with familial chilblain lupus and assesses the effect of cold on fibroblasts.

http://bit.ly/2WawDNK